CARsgen Therapeutics Holdings Limited
HKEX:2171.HK
4.79 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 25.813 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 25.813 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 661.659 | 680.301 | 501.721 | 281.752 | 210.201 |
| General & Administrative Expenses
| 127.842 | 46.822 | 65.816 | 54.8 | 8.752 |
| Selling & Marketing Expenses
| 5.47 | 0 | 0 | 0 | 0 |
| SG&A
| 133.312 | 46.822 | 65.816 | 54.8 | 8.752 |
| Other Expenses
| -27.322 | 75.158 | 44.265 | 12.116 | 11.406 |
| Operating Expenses
| 767.649 | 802.281 | 611.802 | 348.668 | 230.359 |
| Operating Income
| -767.649 | -881.297 | -585.989 | -327.045 | -227.4 |
| Operating Income Ratio
| 0 | 0 | -22.701 | 0 | 0 |
| Total Other Income Expenses Net
| 20.262 | -9.655 | -4,150.789 | -737.004 | -37.733 |
| Income Before Tax
| -747.387 | -890.952 | -4,736.778 | -1,064.049 | -265.133 |
| Income Before Tax Ratio
| 0 | 0 | -183.504 | 0 | 0 |
| Income Tax Expense
| 0.407 | 1.295 | 7.645 | 737.767 | 39.162 |
| Net Income
| -747.794 | -892.247 | -4,744.423 | -1,801.816 | -304.295 |
| Net Income Ratio
| 0 | 0 | -183.8 | 0 | 0 |
| EPS
| -1.34 | -1.62 | -8.63 | -8.55 | -5,363,475.32 |
| EPS Diluted
| -1.34 | -1.62 | -8.63 | -8.55 | -5,363,475.32 |
| EBITDA
| -717.636 | -793.898 | -517.891 | -286.173 | -206.402 |
| EBITDA Ratio
| 0 | 0 | -20.063 | 0 | 0 |